NEW YORK — La Roche-Posay has launched its Anthelios UV Correct SPF 70 Daily Anti-Aging Face Sunscreen formulated with Cellox-B3 Shield technology to correct and protect  skin from signs of sun damage. The sheer finish lotion blends easily on all skin tones in oxybenzone and octinoxate-free formula.

La Roche-Posay’s exclusive Cellox-B3 Shield technology combines photostable UVA/UVB filters to deliver broad spectrum protection and powerful antioxidant protection with Senna Alata, a tropical leaf extract known to defend skin cells against damaging free radicals caused by the sun. Cellox-B3 Shield also contains niacinamide, a form of vitamin B3, known for its ability to help visibly fade skin discoloration.

“Recent research has shown that niacinamide can help visibly reduce signs of sun damage, like discoloration. This La Roche-Posay sunscreen incorporates dermatologist recommended ingredients like UVA/UVB protection, antioxidants, and niacinamide in order to provide a daily antiaging sunscreen solution,” says board certified dermatologist, Dr. Anna Karp.

La Roche-Posay Anthelios UV Correct Daily Anti-Aging Face Sunscreen SPF 70 sells for a suggested $34.99 and can be purchased at select CVS, Walgreens, Target and Ulta stores as well as online at www.laroche-posay.us, Amazon, LovelySkin, Dermstore, Skinstore and Skincarerx.